The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

9 articles for J Vanichtanankul


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel flexible biphenyl PfDHFR inhibitors with improved antimalarial activity.EBI
National Center for Genetic Engineering and Biotechnology (BIOTEC)
Discovery of rigid biphenyl EBI
National Center for Genetic Engineering and Biotechnology (BIOTEC)
Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities.EBI
National Center For Genetic Engineering and Biotechnology At Thailand
Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum.EBI
National Center For Genetic Engineering and Biotechnology At Thailand
Flexible diaminodihydrotriazine inhibitors of Plasmodium falciparum dihydrofolate reductase: Binding strengths, modes of binding and their antimalarial activities.EBI
National Center For Genetic Engineering and Biotechnology (Biotec)
Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum.EBI
National Center For Genetic Engineering and Biotechnology At Thailand
6-Hydrophobic aromatic substituent pyrimethamine analogues as potential antimalarials for pyrimethamine-resistant Plasmodium falciparum.EBI
National Science and Technology Development Agency
Hybrid Inhibitors of Malarial Dihydrofolate Reductase with Dual Binding Modes That Can Forestall Resistance.EBI
National Center For Genetic Engineering and Biotechnology At Thailand
Kinase inhibitorsBDB
Topivert Pharma